{"transactions":[{"id":310320,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2026-04-28T23:37:56.000Z","date":"2026-04-24","kind":"grant","planned":false,"acquired":true,"shares":7105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Stock option granted under the Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":7105,"derivative":{"exercise_price":91.86,"exercise_date":"2026-04-24","expiration_date":"2036-04-23","underlying":"Common Shares","underlying_shares":7105},"source":{"system":"sec-edgar","filing":"0000902132-26-000005","document":"form4-04282026_110450.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800/000090213226000005/form4-04282026_110450.xml","form_type":"4"}},{"id":310319,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2026-04-28T23:37:56.000Z","date":"2026-04-27","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":92.6537,"value":926537.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.43 to $93.04, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":6751103,"source":{"system":"sec-edgar","filing":"0000902132-26-000005","document":"form4-04282026_110450.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000090213226000005/form4-04282026_110450.xml","form_type":"4"}},{"id":310318,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2026-04-28T23:37:56.000Z","date":"2026-04-24","kind":"grant","planned":false,"acquired":true,"shares":2286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the \"Program\"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":6741103,"source":{"system":"sec-edgar","filing":"0000902132-26-000005","document":"form4-04282026_110450.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000090213226000005/form4-04282026_110450.xml","form_type":"4"}},{"id":314172,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2026-02-06T13:04:16.000Z","date":"2026-02-04","kind":"purchase","planned":false,"acquired":true,"shares":5033,"price":108.3328,"value":545238.9824,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.7700 to $108.7150, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":6738817,"source":{"system":"sec-edgar","filing":"0000902132-26-000003","document":"form4-02062026_010212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000090213226000003/form4-02062026_010212.xml","form_type":"4"}},{"id":314171,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2026-02-06T13:04:16.000Z","date":"2026-02-04","kind":"purchase","planned":false,"acquired":true,"shares":4967,"price":109.1388,"value":542092.4196,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.8150 to $109.5204, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":6733784,"source":{"system":"sec-edgar","filing":"0000902132-26-000003","document":"form4-02062026_010212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000090213226000003/form4-02062026_010212.xml","form_type":"4"}},{"id":322684,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2025-04-29T22:22:08.000Z","date":"2025-04-25","kind":"grant","planned":false,"acquired":true,"shares":4516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":4516,"derivative":{"exercise_price":128.4,"exercise_date":"2025-04-25","expiration_date":"2035-04-24","underlying":"Common Shares","underlying_shares":4516},"source":{"system":"sec-edgar","filing":"0001415889-25-011528","document":"form4-04292025_100405.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925011528/form4-04292025_100405.xml","form_type":"4"}},{"id":322683,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2025-04-29T22:22:08.000Z","date":"2025-04-25","kind":"grant","planned":false,"acquired":true,"shares":1635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":6728817,"source":{"system":"sec-edgar","filing":"0001415889-25-011528","document":"form4-04292025_100405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925011528/form4-04292025_100405.xml","form_type":"4"}},{"id":334315,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2024-04-30T22:22:12.000Z","date":"2024-04-26","kind":"grant","planned":false,"acquired":true,"shares":5277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":5277,"derivative":{"exercise_price":107.14,"exercise_date":"2024-04-26","expiration_date":"2034-04-25","underlying":"Common Shares","underlying_shares":5277},"source":{"system":"sec-edgar","filing":"0001415889-24-011801","document":"form4-04302024_100404.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588924011801/form4-04302024_100404.xml","form_type":"4"}},{"id":334314,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2024-04-30T22:22:12.000Z","date":"2024-04-26","kind":"grant","planned":false,"acquired":true,"shares":1866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":6727182,"source":{"system":"sec-edgar","filing":"0001415889-24-011801","document":"form4-04302024_100404.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588924011801/form4-04302024_100404.xml","form_type":"4"}},{"id":344869,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2023-10-30T20:58:18.000Z","date":"2023-10-26","kind":"sale","planned":true,"acquired":false,"shares":23093,"price":94.326,"value":2178270.318,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices\nranging from $94.06 to $94.72, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in\nthis footnote."}],"balance_after":6725316,"source":{"system":"sec-edgar","filing":"0001104659-23-112618","document":"tm2329263-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465923112618/tm2329263-1_4seq1.xml","form_type":"4"}},{"id":344868,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2023-10-30T20:58:18.000Z","date":"2023-10-26","kind":"sale","planned":true,"acquired":false,"shares":26907,"price":93.8141,"value":2524255.9887,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.06 to $94.05, inclusive. The\nreporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission,\nupon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":6748409,"source":{"system":"sec-edgar","filing":"0001104659-23-112618","document":"tm2329263-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465923112618/tm2329263-1_4seq1.xml","form_type":"4"}},{"id":347114,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2023-07-28T21:10:28.000Z","date":"2023-07-27","kind":"sale","planned":true,"acquired":false,"shares":29066,"price":114.0054,"value":3313680.9564,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.86 to $114.46, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":6775316,"source":{"system":"sec-edgar","filing":"0001415889-23-011571","document":"form4-07282023_090718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923011571/form4-07282023_090718.xml","form_type":"4"}},{"id":347113,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2023-07-28T21:10:28.000Z","date":"2023-07-27","kind":"sale","planned":true,"acquired":false,"shares":20934,"price":113.4283,"value":2374508.0322,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.86 to $113.85, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":6804382,"source":{"system":"sec-edgar","filing":"0001415889-23-011571","document":"form4-07282023_090718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923011571/form4-07282023_090718.xml","form_type":"4"}},{"id":349541,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2023-05-03T00:04:29.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":8136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":8136,"derivative":{"exercise_price":110.12,"exercise_date":"2023-04-28","expiration_date":"2033-04-27","underlying":"Common Shares","underlying_shares":8136},"source":{"system":"sec-edgar","filing":"0001415889-23-007139","document":"form4-05032023_120522.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923007139/form4-05032023_120522.xml","form_type":"4"}},{"id":349540,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2023-05-03T00:04:29.000Z","date":"2023-05-02","kind":"sale","planned":false,"acquired":false,"shares":3452,"price":111.75,"value":385761.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.58 to $111.90, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":6825316,"source":{"system":"sec-edgar","filing":"0001415889-23-007139","document":"form4-05032023_120522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923007139/form4-05032023_120522.xml","form_type":"4"}},{"id":349539,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2023-05-03T00:04:29.000Z","date":"2023-05-02","kind":"sale","planned":false,"acquired":false,"shares":46548,"price":110.97,"value":5165431.56,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.51 to $111.50, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":6828768,"source":{"system":"sec-edgar","filing":"0001415889-23-007139","document":"form4-05032023_120522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923007139/form4-05032023_120522.xml","form_type":"4"}},{"id":349538,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2023-05-03T00:04:29.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":1816,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":6875316,"source":{"system":"sec-edgar","filing":"0001415889-23-007139","document":"form4-05032023_120522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923007139/form4-05032023_120522.xml","form_type":"4"}},{"id":357100,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2022-10-31T21:44:50.000Z","date":"2022-10-27","kind":"sale","acquired":false,"shares":9313,"price":98.136,"value":913940.568,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.82 to $98.67, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":6873500,"source":{"system":"sec-edgar","filing":"0001415889-22-010919","document":"form4-10312022_021041.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922010919/form4-10312022_021041.xml","form_type":"4"}},{"id":357099,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2022-10-31T21:44:50.000Z","date":"2022-10-27","kind":"sale","acquired":false,"shares":40687,"price":97.3036,"value":3958991.5732,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.82 to $97.80, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":6882813,"source":{"system":"sec-edgar","filing":"0001415889-22-010919","document":"form4-10312022_021041.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922010919/form4-10312022_021041.xml","form_type":"4"}},{"id":359374,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2022-07-28T21:20:11.000Z","date":"2022-07-26","kind":"sale","acquired":false,"shares":22251,"price":109.6049,"value":2438818.6299,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.33 to $109.85 inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":6923500,"source":{"system":"sec-edgar","filing":"0001415889-22-008020","document":"form4-07282022_020750.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922008020/form4-07282022_020750.xml","form_type":"4"}},{"id":359373,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2022-07-28T21:20:11.000Z","date":"2022-07-26","kind":"sale","acquired":false,"shares":27749,"price":108.767,"value":3018175.483,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.32 to $109.31, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":6945751,"source":{"system":"sec-edgar","filing":"0001415889-22-008020","document":"form4-07282022_020750.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922008020/form4-07282022_020750.xml","form_type":"4"}},{"id":361775,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2022-05-05T21:15:27.000Z","date":"2022-05-03","kind":"sale","acquired":false,"shares":6123,"price":114.8409,"value":703170.8307,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.885 to $114.33, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":6973500,"source":{"system":"sec-edgar","filing":"0001415889-22-004696","document":"form4-05052022_020512.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922004696/form4-05052022_020512.xml","form_type":"4"}},{"id":361774,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2022-05-05T21:15:27.000Z","date":"2022-05-03","kind":"sale","acquired":false,"shares":27055,"price":113.2934,"value":3065152.937,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.885 to $113.86 inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":6979623,"source":{"system":"sec-edgar","filing":"0001415889-22-004696","document":"form4-05052022_020512.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922004696/form4-05052022_020512.xml","form_type":"4"}},{"id":361773,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2022-05-05T21:15:27.000Z","date":"2022-05-03","kind":"sale","acquired":false,"shares":16822,"price":112.5148,"value":1892723.9656,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.875 to $112.86, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":7006678,"source":{"system":"sec-edgar","filing":"0001415889-22-004696","document":"form4-05052022_020512.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922004696/form4-05052022_020512.xml","form_type":"4"}},{"id":361926,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2022-05-03T22:23:35.000Z","date":"2022-04-29","kind":"grant","acquired":true,"shares":1602,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":7023500,"source":{"system":"sec-edgar","filing":"0001415889-22-004556","document":"form4-05032022_030509.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922004556/form4-05032022_030509.xml","form_type":"4"}},{"id":376339,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2021-04-27T23:15:13.000Z","date":"2021-04-23","kind":"grant","acquired":true,"shares":1499,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":7021898,"source":{"system":"sec-edgar","filing":"0001415889-21-002163","document":"form4-04272021_040448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921002163/form4-04272021_040448.xml","form_type":"4"}},{"id":391435,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2020-04-28T21:26:53.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":1974,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":7020399,"source":{"system":"sec-edgar","filing":"0001179110-20-005188","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020005188/edgar.xml","form_type":"4"}},{"id":403747,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2019-04-30T21:17:38.000Z","date":"2019-04-26","kind":"grant","acquired":true,"shares":2241,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":7018425,"source":{"system":"sec-edgar","filing":"0001179110-19-005306","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019005306/edgar.xml","form_type":"4"}},{"id":415404,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-05-01T23:13:12.000Z","date":"2018-04-27","kind":"grant","acquired":true,"shares":2945,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":7016184,"source":{"system":"sec-edgar","filing":"0001179110-18-006030","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018006030/edgar.xml","form_type":"4"}},{"id":417816,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:36:11.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":400,"price":60.87,"value":24348.0,"ownership":{"direct":true},"balance_after":7013239,"source":{"system":"sec-edgar","filing":"0001179110-18-003063","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003063/edgar.xml","form_type":"4"}},{"id":417845,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":107,"price":60.865,"value":6512.555,"ownership":{"direct":true},"balance_after":7012839,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417844,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":1200,"price":60.86,"value":73032.0,"ownership":{"direct":true},"balance_after":7012732,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417843,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":293,"price":60.855,"value":17830.515,"ownership":{"direct":true},"balance_after":7011532,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417842,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":1000,"price":60.85,"value":60850.0,"ownership":{"direct":true},"balance_after":7011239,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417841,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":100,"price":60.845,"value":6084.5,"ownership":{"direct":true},"balance_after":7010239,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417840,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":1000,"price":60.84,"value":60840.0,"ownership":{"direct":true},"balance_after":7010139,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417839,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":600,"price":60.83,"value":36498.0,"ownership":{"direct":true},"balance_after":7009139,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417838,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":200,"price":60.82,"value":12164.0,"ownership":{"direct":true},"balance_after":7008539,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417837,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":400,"price":60.815,"value":24326.0,"ownership":{"direct":true},"balance_after":7008339,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417836,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":900,"price":60.81,"value":54729.0,"ownership":{"direct":true},"balance_after":7007939,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417835,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":100,"price":60.805,"value":6080.5,"ownership":{"direct":true},"balance_after":7007039,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417834,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":400,"price":60.8,"value":24320.0,"ownership":{"direct":true},"balance_after":7006939,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417833,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":300,"price":60.795,"value":18238.5,"ownership":{"direct":true},"balance_after":7006539,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417832,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":800,"price":60.79,"value":48632.0,"ownership":{"direct":true},"balance_after":7006239,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417831,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":400,"price":60.785,"value":24314.0,"ownership":{"direct":true},"balance_after":7005439,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417830,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":2100,"price":60.78,"value":127638.0,"ownership":{"direct":true},"balance_after":7005039,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417829,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":200,"price":60.775,"value":12155.0,"ownership":{"direct":true},"balance_after":7002939,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417828,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":2100,"price":60.77,"value":127617.0,"ownership":{"direct":true},"balance_after":7002739,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417827,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":600,"price":60.765,"value":36459.0,"ownership":{"direct":true},"balance_after":7000639,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417826,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":2500,"price":60.76,"value":151900.0,"ownership":{"direct":true},"balance_after":7000039,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417825,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":175,"price":60.755,"value":10632.125,"ownership":{"direct":true},"balance_after":6997539,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417824,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":2200,"price":60.75,"value":133650.0,"ownership":{"direct":true},"balance_after":6997364,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417823,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":1100,"price":60.745,"value":66819.5,"ownership":{"direct":true},"balance_after":6995164,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417822,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":200,"price":60.7425,"value":12148.5,"ownership":{"direct":true},"balance_after":6994064,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417821,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":2000,"price":60.74,"value":121480.0,"ownership":{"direct":true},"balance_after":6993864,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417820,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":400,"price":60.735,"value":24294.0,"ownership":{"direct":true},"balance_after":6991864,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417819,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":2200,"price":60.73,"value":133606.0,"ownership":{"direct":true},"balance_after":6991464,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417818,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":1079,"price":60.725,"value":65522.275,"ownership":{"direct":true},"balance_after":6989264,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417817,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:35:33.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":4900,"price":60.72,"value":297528.0,"ownership":{"direct":true},"balance_after":6988185,"source":{"system":"sec-edgar","filing":"0001179110-18-003062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003062/edgar.xml","form_type":"4"}},{"id":417875,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":1317,"price":60.715,"value":79961.655,"ownership":{"direct":true},"balance_after":6983285,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":30,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417874,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":100,"price":60.7125,"value":6071.25,"ownership":{"direct":true},"balance_after":6981968,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417873,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":8100,"price":60.71,"value":491751.0,"ownership":{"direct":true},"balance_after":6981868,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417872,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":700,"price":60.705,"value":42493.5,"ownership":{"direct":true},"balance_after":6973768,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417871,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":4800,"price":60.7,"value":291360.0,"ownership":{"direct":true},"balance_after":6973068,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417870,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":500,"price":60.695,"value":30347.5,"ownership":{"direct":true},"balance_after":6968268,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417869,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":4400,"price":60.69,"value":267036.0,"ownership":{"direct":true},"balance_after":6967768,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417868,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":487,"price":60.685,"value":29553.595,"ownership":{"direct":true},"balance_after":6963368,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417867,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":4500,"price":60.68,"value":273060.0,"ownership":{"direct":true},"balance_after":6962881,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417866,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":103,"price":60.675,"value":6249.525,"ownership":{"direct":true},"balance_after":6958381,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417865,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":2799,"price":60.67,"value":169815.33,"ownership":{"direct":true},"balance_after":6958278,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417864,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":600,"price":60.665,"value":36399.0,"ownership":{"direct":true},"balance_after":6955479,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417863,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":1600,"price":60.66,"value":97056.0,"ownership":{"direct":true},"balance_after":6954879,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417862,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":1600,"price":60.65,"value":97040.0,"ownership":{"direct":true},"balance_after":6953279,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417861,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":1500,"price":60.645,"value":90967.5,"ownership":{"direct":true},"balance_after":6951679,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417860,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":1300,"price":60.64,"value":78832.0,"ownership":{"direct":true},"balance_after":6950179,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417859,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":200,"price":60.635,"value":12127.0,"ownership":{"direct":true},"balance_after":6948879,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417858,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":700,"price":60.63,"value":42441.0,"ownership":{"direct":true},"balance_after":6948679,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417857,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":1417,"price":60.62,"value":85898.54,"ownership":{"direct":true},"balance_after":6947979,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417856,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":600,"price":60.61,"value":36366.0,"ownership":{"direct":true},"balance_after":6946562,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417855,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":14,"price":60.605,"value":848.47,"ownership":{"direct":true},"balance_after":6945962,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417854,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":700,"price":60.6,"value":42420.0,"ownership":{"direct":true},"balance_after":6945948,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417853,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":100,"price":60.595,"value":6059.5,"ownership":{"direct":true},"balance_after":6945248,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417852,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":600,"price":60.59,"value":36354.0,"ownership":{"direct":true},"balance_after":6945148,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417851,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":100,"price":60.58,"value":6058.0,"ownership":{"direct":true},"balance_after":6944548,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417850,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":100,"price":60.575,"value":6057.5,"ownership":{"direct":true},"balance_after":6944448,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417849,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":400,"price":60.57,"value":24228.0,"ownership":{"direct":true},"balance_after":6944348,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417848,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":500,"price":60.56,"value":30280.0,"ownership":{"direct":true},"balance_after":6943948,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417847,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":100,"price":60.53,"value":6053.0,"ownership":{"direct":true},"balance_after":6943448,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":417846,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-02-28T23:34:47.000Z","date":"2018-02-27","kind":"purchase","acquired":true,"shares":100,"price":60.52,"value":6052.0,"ownership":{"direct":true},"balance_after":6943348,"source":{"system":"sec-edgar","filing":"0001179110-18-003061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003061/edgar.xml","form_type":"4"}},{"id":424339,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2017-08-03T21:20:09.000Z","date":"2017-08-02","kind":"exercise","acquired":false,"shares":336131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"St. Jude Medical, Inc. stock option that was converted to an Abbott stock option in connection with Abbott's acquisition of St. Jude Medical, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":33.14,"exercise_date":"2017-01-04","expiration_date":"2018-01-03","underlying":"Common shares","underlying_shares":336131},"source":{"system":"sec-edgar","filing":"0001179110-17-011054","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017011054/edgar.xml","form_type":"4"}},{"id":424338,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2017-08-03T21:20:09.000Z","date":"2017-08-02","kind":"exercise","acquired":false,"shares":168413,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"St. Jude Medical, Inc. stock option that was converted to an Abbott stock option in connection with Abbott's acquisition of St. Jude Medical, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":28.5,"exercise_date":"2017-01-04","expiration_date":"2018-01-03","underlying":"Common shares","underlying_shares":168413},"source":{"system":"sec-edgar","filing":"0001179110-17-011054","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017011054/edgar.xml","form_type":"4"}},{"id":424337,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2017-08-03T21:20:09.000Z","date":"2017-08-02","kind":"exercise","acquired":true,"shares":336131,"price":33.14,"value":11139381.34,"ownership":{"direct":true},"balance_after":6943248,"source":{"system":"sec-edgar","filing":"0001179110-17-011054","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017011054/edgar.xml","form_type":"4"}},{"id":424336,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2017-08-03T21:20:09.000Z","date":"2017-08-02","kind":"exercise","acquired":true,"shares":168413,"price":28.5,"value":4799770.5,"ownership":{"direct":true},"balance_after":6607117,"source":{"system":"sec-edgar","filing":"0001179110-17-011054","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017011054/edgar.xml","form_type":"4"}},{"id":424983,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2017-07-06T21:03:02.000Z","date":"2017-07-04","kind":"tax_withholding","acquired":false,"shares":24236,"price":48.71,"value":1180535.56,"ownership":{"direct":true},"balance_after":6438704,"source":{"system":"sec-edgar","filing":"0001179110-17-010183","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017010183/edgar.xml","form_type":"4"}},{"id":426889,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2017-05-02T21:12:05.000Z","date":"2017-04-28","kind":"grant","acquired":true,"shares":3437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes a St. Jude Medical, Inc. restricted stock unit award that was converted to an Abbott award of 58,399 restricted stock units in connection with Abbott's acquisition of St. Jude Medical, in a transaction exempt from Section 16 under Rule 16b-3. The restricted stock units are vested and will settle in shares on July 4, 2017."}],"balance_after":6462940,"source":{"system":"sec-edgar","filing":"0001179110-17-006413","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017006413/edgar.xml","form_type":"4"}},{"id":4497282,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-01-06T13:07:44.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":18316,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing one year after the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_date":"2015-12-17","underlying":"Common Stock","underlying_shares":18316},"source":{"system":"sec-edgar","filing":"0001179110-17-000582","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000582/edgar.xml","form_type":"4"}},{"id":4497281,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:07:44.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":322428,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing one year after the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing one year after the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":69.08,"exercise_date":"2015-12-17","expiration_date":"2022-12-08","underlying":"Common Stock","underlying_shares":322428},"source":{"system":"sec-edgar","filing":"0001179110-17-000582","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000582/edgar.xml","form_type":"4"}},{"id":4497280,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-01-06T13:07:44.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":9693,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_date":"2014-12-17","underlying":"Common Stock","underlying_shares":9693},"source":{"system":"sec-edgar","filing":"0001179110-17-000582","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000582/edgar.xml","form_type":"4"}},{"id":4497279,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:07:44.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":323093,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing one year after the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing one year after the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":59.41,"exercise_date":"2014-12-17","expiration_date":"2021-12-10","underlying":"Common Stock","underlying_shares":323093},"source":{"system":"sec-edgar","filing":"0001179110-17-000582","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000582/edgar.xml","form_type":"4"}},{"id":4497278,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:07:44.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":367512,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, this option, which was fully vested and exercisable immediately prior to the mergers contemplated by the Merger Agreement (the \"Mergers\"), was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) shares of Issuer Common Stock with a Fair Market Value equal to the aggregate exercise price of such option.  Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, this option, which was fully vested and exercisable immediately prior to the mergers contemplated by the Merger Agreement (the \"Mergers\"), was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) shares of Issuer Common Stock with a Fair Market Value equal to the aggregate exercise price of such option.  Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":35.27,"exercise_date":"2013-12-17","expiration_date":"2020-12-10","underlying":"Common Stock","underlying_shares":367512},"source":{"system":"sec-edgar","filing":"0001179110-17-000582","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000582/edgar.xml","form_type":"4"}}],"next_cursor":"2017-01-06T13:07:44.000000Z,4497278"}